Oncologists at Columbia University Medical Center in New York randomly assigned 50 children with acute lymphoblastic leukemia to take either milk thistle capsules or placebo capsules for four weeks while undergoing their "maintenance" round of chemotherapy. At the start of the study, all of the children had signs of liver inflammation from their previous round of treatment. After one month, children taking milk thistle had lower levels of two liver enzymes that show liver damage than those in the placebo group. Children on milk thistle were also somewhat less likely to need their chemotherapy dose lowered at any point. See http://www.raysahelian.com/milkthistle.html

Disclaimer: People should be taking the least amount of prescription drugs that provide adequate treatment, and to regularly monitor and review what is being taken and how much. This applies to most supplements, too. Please do not make any changes in your treatment without first discussing it with your health care provider. Statements made, or products sold through this website, have not been evaluated by the United States Food and Drug Administration. They are not intended to diagnose, treat, cure or prevent any disease.

Some articles contain affiliate links.